Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
12 December 2020 |
Main ID: |
NCT03080233 |
Date of registration:
|
03/03/2017 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Validation of Clinical Decision Support Tool for Acute Stroke Diagnosis (InstaDx)
|
Scientific title:
|
Validation of Clinical Decision Support Tool Information Technology Application for Stroke Diagnosis |
Date of first enrolment:
|
February 1, 2017 |
Target sample size:
|
210 |
Recruitment status: |
Completed |
URL:
|
https://clinicaltrials.gov/show/NCT03080233 |
Study type:
|
Observational |
Study design:
|
|
Phase:
|
|
|
Countries of recruitment
|
Pakistan
| | | | | | | |
Contacts
|
Name:
|
Saadia S Choudhry |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
AKUH |
|
Name:
|
Ayeesha K Kamal |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
AKUH |
| |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
1. Adult men and women, >18 years of age.
2. Patients admitted with neurological deficit consistent with stroke.
3. Confirmation of stroke by objective modality of CT scan and MRI.
4. Consenting to participate in the study.
Exclusion Criteria:
1. Patients presenting with any type of Haemorrhagic stroke such as Sub-Arachnoid
Haemorrhage, Intracerebral Haemorrhage and others.
2. Stroke due to any iatrogenic causes such as post-surgeries, trauma, or any rare or non
atherosclerotic causes eg carotid dissection.
3. Patients signing LAMA (left against Medical Advice) and leaving undiagnosed
Age minimum:
18 Years
Age maximum:
N/A
Gender:
All
|
Health Condition(s) or Problem(s) studied
|
Stroke, Acute
|
Primary Outcome(s)
|
Validation_Primary Outcome Measure_Positive and Negative Predictive Values
[Time Frame: Day 1]
|
Validation_ Primary Outcome Measure_Specificity
[Time Frame: Day 1]
|
Validation_Primary Outcome Measure_ Sensitivity
[Time Frame: Day 1]
|
Secondary Outcome(s)
|
Acceptability
[Time Frame: Day 1]
|
Secondary ID(s)
|
4554-CHS-ERC-16
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|